Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-30 @ 10:21 AM
Study NCT ID:
NCT05445934
Status:
UNKNOWN
Last Update Posted:
2023-01-05
First Post:
2022-06-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)
Sponsor:
Frontier Biotechnologies Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FB2001-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None